Distinguishing naive- from memory-derived human B cells during acute responses.

B cell TLR differentiation memory monocyte naive

Journal

Clinical & translational immunology
ISSN: 2050-0068
Titre abrégé: Clin Transl Immunology
Pays: Australia
ID NLM: 101638268

Informations de publication

Date de publication:
2019
Historique:
received: 24 06 2019
revised: 22 10 2019
accepted: 22 10 2019
entrez: 18 12 2019
pubmed: 18 12 2019
medline: 18 12 2019
Statut: epublish

Résumé

A fundamental question in influenza research is whether antibody titre decline upon successive exposure to variant strains is consequent to recall of cross-reactive memory B cells that competitively inhibit naive B-cell responses. In connection, it is not clear whether naive and memory B cells remain phenotypically distinct acutely after activation such that they may be distinguished Here, we first compared the capacity of anti-Ig and Toll-like-receptor (TLR) 7/8 and TLR9 agonists (R848 and CpG) to augment human B-cell differentiation induced by IL-21 and sCD40L. The conditions that induced optimal differentiation were then used to compare the post-activation phenotype of sort-purified naive and memory B-cell subsets by FACS and antibody-secreting cell (ASC) ELISPOT. Sort-purified naive and memory B cells underwent robust plasmablast and ASC formation when stimulated with R848, but not CpG, and co-cultured with monocytes. This coincided with increased IL-1β and IL-6 production when B cells were co-cultured with monocytes and stimulated with R848, but not CpG. Naive B cells underwent equivalent ASC generation, but exhibited less class-switch and modulation of CD27, CD38 and CD20 expression than memory B cells after stimulation with R848 and monocytes for 6 days. Stimulation with R848, IL-21 and sCD40L in the presence of monocytes induces robust differentiation and ASC generation from both naive and memory B-cells. However, naive and memory B cells retain key phenotypic differences after activation that may facilitate

Identifiants

pubmed: 31844520
doi: 10.1002/cti2.1090
pii: CTI21090
pmc: PMC6851823
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e01090

Informations de copyright

© 2019 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology Inc.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

J Immunol. 2007 Dec 1;179(11):7276-86
pubmed: 18025170
Eur J Immunol. 2007 Aug;37(8):2205-13
pubmed: 17621369
PLoS Pathog. 2008 Aug 29;4(8):e1000138
pubmed: 18769719
Eur J Immunol. 2017 Jan;47(1):131-143
pubmed: 27800605
J Immunol. 2005 Apr 1;174(7):4043-50
pubmed: 15778362
Nat Rev Immunol. 2010 Mar;10(3):170-81
pubmed: 20154735
J Immunol. 2009 Jan 15;182(2):890-901
pubmed: 19124732
J Biol Chem. 1988 Jul 25;263(21):10262-6
pubmed: 2839482
Blood. 2003 Aug 1;102(3):956-63
pubmed: 12689944
J Immunol Methods. 2013 May 31;391(1-2):50-9
pubmed: 23454005
PLoS One. 2011 Mar 14;6(3):e17739
pubmed: 21423809
Eur J Immunol. 2006 Apr;36(4):810-6
pubmed: 16541472
Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7119-24
pubmed: 19359475
Science. 2002 Dec 13;298(5601):2199-202
pubmed: 12481138
J Immunol. 2005 Feb 1;174(3):1259-68
pubmed: 15661881
J Immunol. 2009 Feb 15;182(4):1991-2001
pubmed: 19201852
J Immunol. 2007 Dec 15;179(12):8180-90
pubmed: 18056361
Cell Host Microbe. 2014 Jul 9;16(1):115-27
pubmed: 24981333
Clin Exp Immunol. 1992 Apr;88(1):75-83
pubmed: 1563109
J Immunol Methods. 2010 Jun 30;358(1-2):56-65
pubmed: 20302874
Nat Immunol. 2018 Apr;19(4):386-396
pubmed: 29556002
Cell. 2006 Feb 24;124(4):783-801
pubmed: 16497588
PLoS One. 2011;6(10):e25542
pubmed: 21991317
Front Immunol. 2018 Oct 12;9:2370
pubmed: 30369932
Cell Mol Immunol. 2012 Nov;9(6):434-8
pubmed: 23085951
J Immunol Methods. 2004 Mar;286(1-2):111-22
pubmed: 15087226
BMC Immunol. 2008 Jul 24;9:39
pubmed: 18652679
Blood. 2003 Jun 1;101(11):4500-4
pubmed: 12560217
Blood. 2011 Aug 4;118(5):e16-31
pubmed: 21653326
J Immunol. 2004 May 1;172(9):5154-7
pubmed: 15100251
Blood. 2004 Jan 15;103(2):689-94
pubmed: 14512299
Curr Opin Virol. 2014 Oct;8:85-9
pubmed: 25108824
Immunity. 2018 Mar 20;48(3):584-598.e5
pubmed: 29548673
Immunology. 2018 Mar;153(3):357-367
pubmed: 28940186
J Leukoc Biol. 1995 Sep;58(3):365-72
pubmed: 7665993
Int Immunol. 2006 May;18(5):701-12
pubmed: 16569679
Curr Opin Virol. 2017 Feb;22:105-111
pubmed: 28088686
J Exp Med. 2017 Nov 6;214(11):3207-3217
pubmed: 28899868
Nat Rev Immunol. 2009 Jul;9(7):491-502
pubmed: 19521398
Clin Microbiol Rev. 2017 Oct;30(4):991-1014
pubmed: 28855265
J Immunol. 2008 Feb 15;180(4):2117-24
pubmed: 18250417
J Immunol. 2003 Jan 15;170(2):686-94
pubmed: 12517929

Auteurs

Maria Auladell (M)

Department of Microbiology and Immunology University of Melbourne at the Peter Doherty Institute for Infection and Immunity Melbourne VIC Australia.

Thi Ho Nguyen (TH)

Department of Microbiology and Immunology University of Melbourne at the Peter Doherty Institute for Infection and Immunity Melbourne VIC Australia.

Beatriz Garcillán (B)

Department of Microbiology and Immunology University of Melbourne at the Peter Doherty Institute for Infection and Immunity Melbourne VIC Australia.

Fabienne Mackay (F)

Department of Microbiology and Immunology University of Melbourne at the Peter Doherty Institute for Infection and Immunity Melbourne VIC Australia.

Katherine Kedzierska (K)

Department of Microbiology and Immunology University of Melbourne at the Peter Doherty Institute for Infection and Immunity Melbourne VIC Australia.

Annette Fox (A)

WHO Collaborating Centre for Reference and Research on Influenza VIDRL at the Peter Doherty Institute for Infection and Immunity Melbourne VIC Australia.

Classifications MeSH